Effects of propentofylline on tumor necrosis factor-α and cytokine- induced neutrophil chemoattractant production in rats with cerulein-induced pancreatitis and endotoxemia

Pancreas

Volumn 14, Issue 3, 1997, Pages 267-275

  Sugita, Hiroki ^a   Yamaguchi, Yasuo ^a   Ikei, Satoshi ^a   Ogawa, Michio ^a,b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Department of Surgery II ^*  (Japan)

Author keywords

Cytokine induced neutrophil chemoattractant; Lung compliance; Lung myeloperoxide; Pancreatitis; Propentofylline; Septic complication; Tumor necrosis factor

Indexed keywords

AMYLASE; CERULETIDE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PROPENTOFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG COMPLIANCE; LUNG INFILTRATE; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030892823     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199704000-00008     Document Type: Article

References (61)

1. Renner IG, Savage WT, Patoja JL, et al. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985;30:1005-18.
2. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988;3:105-12.
3. Inoue S, Nakao A, Kishimoto W, et al. Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis. Arch Surg 1995;130:1995:93-8.
4. Borregaard N. The human neutrophil. Function and dysfunction. Eur J Haematol 1988;41:401-13.
5. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-71.
6. Kevin JT, Bruce B, Stephen FL, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234: 470-6.
7. Bagglioni M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
8. Sameshima H, Ikei S, Mori K, et al. The role of tumor necrosis factor-α in aggravation of cerulein-induced pancreatitis in rats. Int J Pancreatol 1993;14:107-15.
9. Watanabe K, Iida M, Takaishi K, et al. Chemoattractant for neutrophil in lipopolysaccharide-induced inflammatory exudate from rats are not interleukin-8 counterparts but gro-gene-products/ melanoma-growth-stimulating-activity-related factors. Eur J Biochem 1993;214:267-70.
10. Watanabe K, Kinoshita S, Nakagawa H. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelial cell line of normal rat kidney (NRK-52 cell). Biochem Biophys Res Commun 1989;161:1093-9.
11. Watanabe K, Suematsu M, Iida M, et al. Effect of rat CINC/gro, a member of interleukin-8 family, on leukocytes in microcirculation of the rat mesentery. Exp Mol Pathol 1992;56:60-9.
12. Goto M, Demura N, Sakaguchi T. Effects of propentofylline on disorder of learning and memory in rodents. Jpn J Pharmacol Ther 1987;45:373-8.
13. Deleo J, Schbert P, Kreutzberg GW. Propentofylline (HWA285) protects hippocampal neurons of Mongolian gerbils against ischemic damage in the presence of an adenosine antagonist. Neurosci Lett 1988;84:307-11.
14. Otomo E, Hayashi M, Makishita H, et al. Clinical open study of HWA285 in cerebrovascular disorders with special regard to long-term administered patients. Jpn J Pharmacol Ther 1986;14:2481-92.
15. Miki S, Miki Y. Differential effects of propentofylline on the production of cytokines by peripheral blood mononuclear cell in vitro. Clin Ther 1991;13:747-53.
16. National Institutes of Health, Public Health Service. Guide for the care and use of laboratory animals, NIH publication No. 86-23. Bethesda, MD: NIH, 1985.
17. Ogawa M. Mechanisms of the development of organ failure following surgical insult: the 'second attack' theory. Clin Intens Care 1996;7:34-8.
18. Inada K, Endo S, Takahashi K, et al. Establishment of a new perchloric acid treatment method to allow determination of the total endotoxin content in human plasma by the limulus test and clinical application. Microbiol Immunol 1991;5:303-14.
19. Welbourn R, Goldman G, Kobzik L, Paterson I, Shepro D, Hechtman HB. Interleukin-2 induced early multisystem organ edema mediated by neutrophils. Ann Surg 1991;214:181-6.
20. Nakagawa H, Ikesue A, Kato H, et al. Changes in the levels of rat interleukin-8/CINC and gelatinase in the exudate of carrageenaninduced inflammation in rats. J Pharmacobiodyn 1992;15:461-6.
21. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of α-amylase activities in human serum and urine. Clin Chim Acta 1969;26:437-44.
22. Sanchez-Cantu L, Rode HN, Christou NV. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 1989;124:1432-6.
23. Warren JS, Yabroff KR, Remick DG, et al. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 1989;84:1873-82.
24. Goldman G, Welbourn R, Klausner JM, Kobzik L, Valeri CR, Shepro D. Leukocytes mediate acid aspiration-induced multiorgan edema. Surgery 1993;114:13-20.
25. Stewart TE, Valenza F, Ribeiro SP, et al. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995;151:713-8.
26. Buggy BP, Nostrant TT. Lethal pancreatitis. Am J Gastroenterol 1983;78:810-4.
27. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991;5:338-43.
28. Tracey KJ, Fong Y, Heese DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock lethal bacteremia. Nature 1987;330:662-1.
29. Ohlson K, Bjork P, Bergenfeldt R, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-2.
30. Chang S, Fernyak S, Voelkel NF. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury. Am J Physiol 1990;258:H153-5.
31. Chang S, Feddersen CO, Henson PM, Voelkei NF. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987;79:1498-509.
32. Ulich TR, Yin S, Guo K, del Castillo J, Eisenberg SP, Thompson RC. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin-and IL-1-induced acute inflammation. Am J Pathol 1991;138: 521-4.
33. Ulich TR, Watson LR, Yin S, et al. The intratracheal administration of endotoxin and cytokines. Am J Pathol 1991;38:1485-96.
34. Rinaldo JE, Dauber JH, Christman J, Rogers RM. Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hypoxia. Am Rev Respir Dis 1984;133:1065-71.
35. Meyrick M, Bern LC Jr, Christman BW. Respose of cultured human pulmonary artery endothelial cells to endotoxin. Am J Physiol 1995;268:L239-44.
36. Rose CE Jr, Juliano CA, Tracey DE, Yoshimura T, Fu SM. Role of interleukin-1 in endotoxin-induced lung injury in the rat. Am J Respir Cell Mol Biol 1994;10:214-21.
37. Huang S, Paulauskis JD, Kobzik L. Rat KC cDNA cloning and mRNA expression in lung macrophages and fibroblasts. Biochem Biophys Res Commun 1992;184:922-9.
38. Gough DB. Educate the phagocyte! Br J Surg 1991;78:1-2.
39. Griffin JD, Spertini O, Ernst TJ, et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocyte, and their precursors. J Immunol 1990;145:576-84.
40. Frevert CW, Huang S, Danaee H, Paulauskis JD, Kobzik L. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol 1995;154:335-44.
41. Mattila P, Majuri ML, Mattila PS, Renkonen R. TNF-α-induced expression of endothelial adhesion molecules. ICAM-I and VCAM-I, is linked to protein kinase C activation. Scand J Immunol 1992;36:159-65.
42. Diener AM, Beatty PG, Ochs HO, Harlan JM. The role of neutrophil membrane glycoprotein 150 (GP-150) in neutrophil-mediated endothelial cell injury in vitro. J Immunol 1985;135:537-43.
43. Verghese MW, McConnell RT, Strickland AB, et al. Differential regulation of human monocyte-derived TNF-α and IL-1β by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 1995;272:1313-20.
44. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-4.
45. Fredholm BB, Duner-Engstrom M. Propentofylline and a hydroxy metabolite augment A2-receptor mediated cyclic AMP accumulation and attenuate A1-receptor mediated inhibition of acetylcholine release in the rat hippocampus. Pharmacol Toxicol 1989;65:347-51.
46. Chouaib S, Marchiol C, Frandelizi D. Inhibition of human tumor necrosis factor by adenylate cyclase activators. Immunobiology 1987;175:127-32.
47. Miki S, Miki Y. Differential effects of propentofylline on the production of cytokines by peripheral blood mononuclear cells in vitro. Clin Ther 1991;13:747-53.
48. van Leenen D, van der Poll T, Levi M, et al. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 1993;151:2318-25.
49. Kamoi H, Kanazawa H, Hirata K, Kurihara N, Yano Y, Otani S. Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 1995; 211:1031-5.
50. Modig J. Adult respiratory distress syndrome: pathophysiology and inflammatory mediators in bronchoalveolar lavage. In: Second Vienna Schock Forum. New York: Alan R. Liss, 1989:17-25.
51. Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983;128:552-9.
52. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141:471-501.
53. Weiland JE, Davis WB, Holter JP, Mohammed PM, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis 1986;133:218-25.
54. Malmros C, Holst E, Hansson L, Martensson L, Thome J. Dynamic accumulation of neutrophils in lungs and visceral organs during early abdominal sepsis in the pig. World J Surg 1994;18:811-7.
55. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 1985;59: 1978-85.
56. Boxer L, Allen J, Bachner R. Diminished polymorphonuclear leukocyte adherence: function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine. J Clin Invest 1980;66:268-74.
57. Duffey ME, Hainau B, Ho S, Bentzel CJ. Regulation of epithelial tight junction permeability by cyclic AMP. Nature 1981;294: 451-3.
58. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986;133:913-27.
59. Bernard GR, Brigham KL. The adult respiratory distress syndrome. Annu Rev Med 1985;36:195-205.
60. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994;74:1133-40.
61. Byrne K, Cooper KR, Carey PD, et al. Pulmonary compliance: early assessment of evolving lung injury after onset of sepsis. J Appl Physiol 1990;69:2290-5.